Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test

被引:48
|
作者
Rosenfield, Robert L. [1 ]
Mortensen, Monica
Wroblewski, Kristen [2 ]
Littlejohn, Elizabeth
Ehrmann, David A.
机构
[1] Univ Chicago, Pritzker Sch Med, Sect Adult & Pediat Endocrinol, Dept Pediat & Med,Med Ctr, Chicago, IL 60637 USA
[2] Univ Chicago, Pritzker Sch Med, Dept Hlth Studies, Chicago, IL 60637 USA
关键词
glucose intolerance; functional adrenal hyperandrogenism; functional ovarian hyperandrogenism; obesity; LUTEINIZING-HORMONE; INSULIN-SECRETION; FREE TESTOSTERONE; PRODUCTION-RATES; NORMAL WOMEN; HYPERANDROGENISM; HIRSUTISM; OBESITY; DEHYDROEPIANDROSTERONE; STEROIDOGENESIS;
D O I
10.1093/humrep/der291
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Polycystic ovary syndrome (PCOS) patients typically have 17-hydroxyprogesterone (17OHP) hyperresponsiveness to GnRH agonist (GnRHa) (PCOS-T). The objective of this study was to determine the source of androgen excess in the one-third of PCOS patients who atypically lack this type of ovarian dysfunction (PCOS-A). METHODS: Aged-matched PCOS-T (n = 40), PCOS-A (n = 20) and controls (n 39) were studied prospectively in a General Clinical Research Center. Short (4 h) and long (4-7 day) dexamethasone androgen-suppression tests (SDAST and LDAST, respectively) were compared in subsets of subjects. Responses to SDAST and low-dose adrenocorticotropic hormone (ACTH) were then evaluated in all. RESULTS: Testosterone post-SDAST correlated significantly with testosterone post-LDAST and 17OHP post-GnRHa (r = 0.671-0.672), indicating that all detect related aspects of ovarian dysfunction. An elevated dehydroepiandrosterone peak in response to ACTH, which defined functional adrenal hyperandrogenism, was similarly prevalent in PCOS-T (27.5%) and PCOS-A (30%) and correlated significantly with baseline dehydroepiandrosterone sulfate (DHEAS) (r = 0.708). Functional ovarian hyperandrogenism was detected by subnormal testosterone suppression by SDAST in most (92.5%) PCOS-T, but significantly fewer PCOS-A (60%, P < 0.01). Glucose intolerance was absent in PCOS-A, but present in 30% of PCOS-T (P < 0.001). Most of the PCOS-A cases with normal testosterone suppression in response to SDAST (5/8) lacked evidence of adrenal hyperandrogenism and were obese. CONCLUSIONS: Functional ovarian hyperandrogenism was not demonstrable by SDAST in 40% of PCOS-A. Most of these cases had no evidence of adrenal hyperandrogenism. Obesity may account for most hyperandrogenemic anovulation that lacks a glandular source of excess androgen, and the SDAST seems useful in making this distinction.
引用
收藏
页码:3138 / 3146
页数:9
相关论文
共 24 条
  • [1] DETERMINATION OF THE SOURCE(S) OF ANDROGEN OVERPRODUCTION IN HIRSUTISM ASSOCIATED WITH POLYCYSTIC-OVARY-SYNDROME BY SIMULTANEOUS ADRENAL AND OVARIAN VENOUS CATHETERIZATION - COMPARISON WITH THE DEXAMETHASONE SUPPRESSION TEST
    WAJCHENBERG, BL
    ACHANDO, SS
    OKADA, H
    CZERESNIA, CE
    PEIXOTO, S
    LIMA, SS
    GOLDMAN, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (05): : 1204 - 1210
  • [2] Extended low-dose dexamethasone suppression test for diagnosis of atypical Cushing's syndrome in dogs
    Fowler, K. M.
    Frank, L. A.
    Morandi, F.
    Whittemore, J. C.
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2017, 60 : 25 - 30
  • [3] Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome
    Buyalos, RP
    Geffner, ME
    Azziz, R
    Judd, HL
    HUMAN REPRODUCTION, 1997, 12 (06) : 1138 - 1141
  • [4] Low-dose dexamethasone suppression test in chronic fatigue syndrome and health
    Gaab, J
    Hüster, D
    Peisen, R
    Engert, V
    Schad, T
    Schürmeyer, TH
    Ehlert, U
    PSYCHOSOMATIC MEDICINE, 2002, 64 (02): : 311 - 318
  • [5] The low-dose dexamethasone suppression test: A reevaluation in patients with Cushing's syndrome
    Findling, JW
    Raff, H
    Aron, DC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03): : 1222 - 1226
  • [6] Long-term, low-dose dexamethasone treatment further reduces androgen levels in metformin-treated polycystic ovary syndrome women
    Vanky, E.
    Salvesen, K. A.
    Carlsen, S. M.
    HUMAN REPRODUCTION, 2003, 18 : 171 - 172
  • [7] An Optimized Pathway for the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome Based on Low-Dose Dexamethasone Suppression Test
    Chen, Kang
    Chen, Shi
    Lu, Lin
    Zhu, Huijuan
    Zhang, Xiaobo
    Tong, Anli
    Pan, Hui
    Wang, Renzhi
    Lu, Zhaolin
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [8] The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome
    Dias, R
    Storr, HL
    Perry, LA
    Isidori, AM
    Grossman, AB
    Savage, MO
    HORMONE RESEARCH, 2006, 65 (03) : 159 - 162
  • [9] Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome
    Martin, N. M.
    Dhillo, W. S.
    Banerjee, A.
    Abdulali, A.
    Jayasena, C. N.
    Donaldson, M.
    Todd, J. F.
    Meeran, K.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (07): : 2582 - 2586
  • [10] The usefulness of the combined high-dose dexamethasone suppression test and desmopressin stimulation test in establishing the source of ACTH secretion in ACTH-dependent Cushing's syndrome
    Qiao, Jingtao
    Li, Jiaqi
    Zhang, Weiwei
    Wang, Chun
    Li, Jianwei
    Jiang, Shu
    Tan, Huiwen
    Chen, Yaxi
    Liu, Hui
    Cai, Bowen
    Yu, Yerong
    ENDOCRINE JOURNAL, 2021, 68 (07) : 839 - 848